Press release
Obsessive Compulsive Disorder Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight
Unlock key insights into the Obsessive Compulsive Disorder Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Obsessive Compulsive Disorder Drugs Market Outlook [https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Obsessive Compulsive Disorder Market Report
* In March 2025, Biohaven Pharmaceuticals Inc . announced a study's purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compulsive Disorder (OCD).
* In March 2025, Yale University announced a study, all subjects will receive the study drug at their optimal dose. The primary endpoint of these studies will be the change from baseline of placebo vs. active scores utilizing the Massachusetts General Hospital Hairpulling Scale (MGH-HPS) at the end of Week 12.
* Among the 7MM, the United States had the largest Obsessive-Compulsive Disorder Drugs Market Share in 2023, which accounted for approximately 55% of the total 7MM market.
* The Obsessive-Compulsive Disorder Treatment Market Size in the US was ~USD 600 million in 2023.
* In 2023, selective serotonin reuptake inhibitors (SSRIs) made approximately USD 290 million in revenue across the seven major markets, with antipsychotics ranking second, generating around USD 160 million.
* The Obsessive-Compulsive Disorder Treatment Market Size in EU4 and the UK was ~USD 380 million in 2023.
* The leading Obsessive Compulsive Disorder Companies such as Biohaven Pharmaceutical Holding Company Ltd., Alkermes plc, Intra-Cellular Therapies, Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Mylan N.V., Cipla Limited, Eli Lilly and Company, Pfizer Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Impel NeuroPharma, Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson), Novartis International AG, Sun Pharmaceutical Industries Ltd., and Allergan plc (now part of AbbVie Inc.) and others.
* Promising Obsessive Compulsive Disorder Pipeline Therapies such as Olanzapine, SXC-2023, Valbenazine Oral Capsule, Escitalopram, Seroquel XR, Sertraline and others.
Stay ahead in the competitive landscape of the Obsessive Compulsive Disorder Market. Access DelveInsight's in-depth market analysis and strategic insights today! Click here for more @ Obsessive Compulsive Disorder Treatment Market Size [https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Obsessive Compulsive Disorder Epidemiology Segmentation in the 7MM
* Total Obsessive-Compulsive Disorder Prevalent Cases
* Total Obsessive-Compulsive Disorder Diagnosed Cases
* Obsessive-Compulsive Disorder Gender specific Cases
* Obsessive-Compulsive Disorder Severity-specific Cases
* Obsessive-Compulsive Disorder Age-specific Cases
Download the report to understand which factors are driving Obsessive Compulsive Disorder epidemiology trends @ Obsessive Compulsive Disorder Prevalence [https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Obsessive Compulsive Disorder Emerging Therapies
* Troriluzole: Biohaven Pharmaceuticals
Troriluzole is a new chemical entity ("NCE") and tripeptide prodrug of the active metabolite, riluzole. Troriluzole is optimized for improved bioavailability, pharmacokinetics, tolerability, and dosing compared to its active metabolite. Based on its Obsessive-Compulsive Disorder Mechanism of Action, preclinical data, and Obsessive-Compulsive Disorder Clinical Trials, troriluzole has the potential for therapeutic benefit in neurological and neuropsychiatric illnesses.
Obsessive Compulsive Disorder Market Outlook
OCD can be treated using pharmacotherapy, specialized psychotherapy, anatomically targeted treatments, or their combination. First-line treatments include cognitive-behavioral therapy and pharmacotherapy with the selective serotonin reuptake inhibitors (SSRIs). In this article we review evidence-based pharmacotherapies for OCD, as well as alternatives that may be considered in refractory patients. Other treatment modalities are reviewed in other articles in this issue. Unfortunately, even with optimal treatment, many patients continue to experience significant symptoms. Remission of moderate or severe OCD is uncommon, and long-term management is often necessary. The development of new, more effective treatment interventions represents an urgent clinical need.
To learn more about Obsessive Compulsive Disorder Treatment guidelines, visit @ Obsessive Compulsive Disorder Market Drivers and Barriers [https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Obsessive Compulsive Disorder Companies
Biohaven Pharmaceutical Holding Company Ltd., Alkermes plc, Intra-Cellular Therapies, Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Mylan N.V., Cipla Limited, Eli Lilly and Company, Pfizer Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Impel NeuroPharma, Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson), Novartis International AG, Sun Pharmaceutical Industries Ltd., and Allergan plc (now part of AbbVie Inc.) and others.
Scope of the Obsessive Compulsive Disorder Market Report
* Coverage- 7MM
* Study Period- 2020-2034
* Obsessive Compulsive Disorder Companies- Biohaven Pharmaceutical Holding Company Ltd., Alkermes plc, Intra-Cellular Therapies, Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Mylan N.V., Cipla Limited, Eli Lilly and Company, Pfizer Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Impel NeuroPharma, Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson), Novartis International AG, Sun Pharmaceutical Industries Ltd., and Allergan plc (now part of AbbVie Inc.) and others.
* Obsessive Compulsive Disorder Pipeline Therapies- Olanzapine, SXC-2023, Valbenazine Oral Capsule, Escitalopram, Seroquel XR, Sertraline and others.
* Obsessive Compulsive Disorder Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
* Obsessive Compulsive Disorder Unmet Needs, KOL's views, Analyst's views, Obsessive Compulsive Disorder Market Access and Reimbursement
Explore the dynamics of the Obsessive Compulsive Disorder Market with DelveInsight. From market size to emerging drugs-find it all in our latest report. Read now! @ Obsessive Compulsive Disorder Ongoing Clinical Trials Analysis [https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Contents
1. Key Insights
2. Obsessive Compulsive Disorder Market Report Introduction
3. Obsessive Compulsive Disorder Market Overview at a Glance
4. Obsessive Compulsive Disorder Executive Summary
5. Obsessive Compulsive Disorder Epidemiology and Market Methodology
6. Disease Background and Overview
7. Obsessive Compulsive Disorder Epidemiology and Patient Population
8. Obsessive Compulsive Disorder Patient Journey
9. OCD Marketed Therapies
10. Obsessive Compulsive Disorder Emerging Therapies
11. Obsessive Compulsive Disorder: The 7MM Market Analysis
12. KOL Views
13. SWOT Analysis
14. OCD Unmet needs
15. Market Access and Reimbursement
16. Appendix
17. DelveInsight Capabilities
18. Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=obsessive-compulsive-disorder-treatment-market-size-in-7mm-is-expected-to-grow-at-a-decent-cagr-by-2034-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-market
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Obsessive Compulsive Disorder Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight here
News-ID: 3995351 • Views: …
More Releases from ABNewswire
Photo Retouching Experts at Zenith Clipping Reveal Top 5 Mistakes Costing E-Comm …
Image: https://www.abnewswire.com/upload/2026/02/9f6dcba191fb81afea9121b9f9d6138f.jpg
In digital commerce, product imagery plays a central role in how customers evaluate, compare, and ultimately purchase products. As online shopping continues to rely heavily on visual presentation, professional editing standards have become increasingly important for brand credibility and customer trust.
Now, Photo retouching experts at Zenith Clipping [https://zenithclipping.com/] have published a professional insight report that Reveals top 5 mistakes costing E-commerce brands millions in potential lost sales, avoidable returns,…
Hackensack Homicide Defense Attorney Adam M. Lustberg Explains What to Expect Wh …
HACKENSACK, NJ - Individuals charged with homicide in New Jersey face some of the most severe penalties in the criminal justice system, with sentences ranging from five years in state prison to life without parole depending on the specific offense. Hackensack homicide defense attorney Adam M. Lustberg of Lustberg Law Offices, LLC (https://www.lustberglaw.com/blog/what-to-expect-when-youre-charged-with-homicide-in-nj/) is providing an in-depth overview of how homicide cases are classified, prosecuted, and defended under New Jersey…
Manhattan LGBTQ Divorce Attorney Juan Luciano Discusses Non-Biological Parent Ri …
MANHATTAN, NY - Non-biological parents navigating a same gender divorce in New York may face complex legal questions about custody, visitation, and decision-making authority over their children. Manhattan LGBTQ divorce attorney Juan Luciano of Juan Luciano Divorce Lawyer (https://divorcelawfirmnyc.com/non-biological-parent-rights-same-sex-divorce-new-york/) is providing guidance on how non-biological parents can establish and protect their parental rights when a marriage ends.
According to Manhattan LGBTQ divorce attorney Juan Luciano, New York law recognizes several pathways…
Queens Burn Injury Attorney Keetick L. Sanchez Explains Compensation Options for …
JACKSON HEIGHTS, NY - Burn injuries cause severe physical pain, permanent scarring, and overwhelming medical expenses that can exceed tens of thousands of dollars. Queens burn injury attorney Keetick L. Sanchez of K L Sanchez Law Office, P.C. (https://accidentlawyer-queens.com/queens-burn-injury-attorney/) guides burn victims through the legal process of recovering compensation for injuries caused by workplace accidents, defective products, and property owner negligence.
According to Queens burn injury attorney Keetick L. Sanchez, burns…
More Releases for Obsessive
Emerging Trends Influencing The Growth Of The Obsessive-Compulsive Disorder Mark …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Big Is the Obsessive-Compulsive Disorder Market Size Expected to Be by 2034?
The market size of obsessive-compulsive disorder has seen a robust increase in recent times. The sector is projected to progress from $0.62 billion in 2024 to $0.67 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.64%. The historic…
Obsessive-Compulsive Disorder Drugs Market: Trends, Growth, and Outlook to 2034
The global Obsessive-Compulsive Disorder (OCD) Drugs Market is witnessing steady growth, supported by a rising prevalence of OCD, increasing awareness about mental health, and advancements in pharmacological treatments. As mental health continues to take center stage in global healthcare discussions, pharmaceutical companies are channeling investments into developing effective OCD therapeutics. The global obsessive-compulsive disorder drugs market is projected to grow at a CAGR of approximately 4.80% during the forecast period…
Obsessive Compulsive Disorder Market is tend to be around 10.2%, Size, Trends
Obsessive compulsive disorder is a type of mental illness characterized by repeated unreasonable thoughts and uncontrollable fears resulting in repetitive action or activity by a person. The obsessive-compulsive usually induces individual to throws themselves into particular thought or fear. There are common obsessions associated with it such as contamination, sexual, violent, identity, responsibility and many more.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-obsessive-compulsive-disorder-market
The global obsessive compulsive disorder market is expected to witness significant growth…
Obsessive Compulsive Disorder Drugs Market to Witness Robust Expansion by 2029
Obsessive Compulsive Disorder Drugs Market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are propelling market growth include increasing R&D investment and a rise in clinical trials by market players, which are expected to fuel the market growth during the forecast period. Obsessive-compulsive disorder (OCD) refers to an anxiety disorder that is characterized by unreasonable and uncontrollable thoughts and fears leading an…
Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape, 2022
Global Obsessive Compulsive Disorder Market report from Global Insight Services is the single authoritative source of intelligence on Obsessive Compulsive Disorder market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories,…
Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Read more about Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/obsessive-compulsive-disorder-ocd-drug-pipeline-landscape-2022/
Obsessive-compulsive disorder (OCD) is a common, chronic, and long-lasting disorder in which a person experiences uncontrollable, reoccurring thoughts ("obsessions") and/or…
